These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23233676)

  • 21. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi.
    Upadhyay A; Burman JD; Clark EA; Leung E; Isenman DE; van den Elsen JM; Bagby S
    J Biol Chem; 2008 Aug; 283(32):22113-20. PubMed ID: 18550524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.
    Garcia BL; Ramyar KX; Ricklin D; Lambris JD; Geisbrecht BV
    Adv Exp Med Biol; 2012; 946():113-33. PubMed ID: 21948365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement.
    Katschke KJ; Stawicki S; Yin J; Steffek M; Xi H; Sturgeon L; Hass PE; Loyet KM; Deforge L; Wu Y; van Lookeren Campagne M; Wiesmann C
    J Biol Chem; 2009 Apr; 284(16):10473-9. PubMed ID: 19196712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
    Haupt K; Reuter M; van den Elsen J; Burman J; Hälbich S; Richter J; Skerka C; Zipfel PF
    PLoS Pathog; 2008 Dec; 4(12):e1000250. PubMed ID: 19112495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
    van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
    Front Immunol; 2019; 10():2097. PubMed ID: 31552043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
    Wiesmann C; Katschke KJ; Yin J; Helmy KY; Steffek M; Fairbrother WJ; McCallum SA; Embuscado L; DeForge L; Hass PE; van Lookeren Campagne M
    Nature; 2006 Nov; 444(7116):217-20. PubMed ID: 17051150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
    Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
    J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models.
    Zwarthoff SA; Berends ETM; Mol S; Ruyken M; Aerts PC; Józsi M; de Haas CJC; Rooijakkers SHM; Gorham RD
    Front Immunol; 2018; 9():1691. PubMed ID: 30083158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.
    Sharp JA; Cunnion KM
    Mol Immunol; 2011 Jan; 48(4):683-90. PubMed ID: 21163532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
    Harris CL; Pettigrew DM; Lea SM; Morgan BP
    J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.
    Ricklin D; Ricklin-Lichtsteiner SK; Markiewski MM; Geisbrecht BV; Lambris JD
    J Immunol; 2008 Dec; 181(11):7463-7. PubMed ID: 19017934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.
    Ricklin D
    Immunobiology; 2012 Nov; 217(11):1057-66. PubMed ID: 22964231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity.
    Mannes M; Dopler A; Zolk O; Lang SJ; Halbgebauer R; Höchsmann B; Skerra A; Braun CK; Huber-Lang M; Schrezenmeier H; Schmidt CQ
    Blood; 2021 Jan; 137(4):443-455. PubMed ID: 33507296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of properdin in the assembly of the alternative pathway C3 convertases of complement.
    Hourcade DE
    J Biol Chem; 2006 Jan; 281(4):2128-32. PubMed ID: 16301317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus.
    Hammel M; Sfyroera G; Pyrpassopoulos S; Ricklin D; Ramyar KX; Pop M; Jin Z; Lambris JD; Geisbrecht BV
    J Biol Chem; 2007 Oct; 282(41):30051-61. PubMed ID: 17699522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.
    Hebecker M; Józsi M
    J Biol Chem; 2012 Jun; 287(23):19528-36. PubMed ID: 22518841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement Evasion Mediated by Enhancement of Captured Factor H: Implications for Protection of Self-Surfaces from Complement.
    Herbert AP; Makou E; Chen ZA; Kerr H; Richards A; Rappsilber J; Barlow PN
    J Immunol; 2015 Nov; 195(10):4986-98. PubMed ID: 26459349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.
    Neth O; Jack DL; Johnson M; Klein NJ; Turner MW
    J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase.
    Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
    J Immunol; 2009 Dec; 183(11):7347-51. PubMed ID: 19890040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.